FDA new drug approvals hit 16-year high in 2012 | Reuters

January 3, 2013

U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to generic drug makers because of patent expirations.

Share on Facebook
Share on Twitter
Please reload

Featured Review

U.S. Healthcare Outlook

October 24, 2014

1/2
Please reload

Tag Cloud
Please reload

Gryphon Analytics Copyright 2012-2017

  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey Google+ Icon